Wyss Zurich
Myoung-Ok Kwon, Prof. PhD, currently serves as Co-Chair and Member of the Evaluation Board at Wyss Zurich, focusing on regenerative medicine, robotics, and medical devices. As an Adjunct Professor at the Korea Advanced Institute of Science and Technology, expertise encompasses venture capital, biotech, digital health, and healthcare digital transformation. Myoung-Ok holds the position of Investment Partner in Digital Health at Swisscom Ventures and serves on the Board of Directors at Medimaps Group and Neo Medical, while acting as a Board Observer for Nanolive SA. Previous roles include Independent Board Director at NLS Pharmaceutics AG and Head of Healthcare Investment at PMG Fonds Management AG. The foundation of Myoung-Ok's career in biotech investment was established as Founder of the Biotech Core Value Fund and Venture Partner at Arcus Ventures. Academic credentials include a PhD in Biochemical Sciences from the University of Basel and multiple executive education programs at Harvard Business School.
This person is not in any teams
Wyss Zurich
Wyss Zurich is a joint research and development center of the University of Zurich and the ETH Zurich, made possible by a generous donation from the Swiss entrepreneur and philanthropist Dr. hc. mult. Hansjörg Wyss. The mission of Wyss Zurich is to drive the clinical translation and technology transfer of outstanding scientific discoveries into new therapies for patients and breakthrough innovations in the emerging fields of Regenerative Medicine, Robotics and Medical Devices/Bionics Technologies. Wyss Zurich brings together some of the world’s leading experts to form multidisciplinary teams, pooling their knowledge and expertise.